Skip to content

Medical-device intelligence

Immuno Concepts Inc: FDA clearances and recalls

Research Immuno Concepts Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

36 clearance records and 2 recall records in the covered releases, across 1 source company names and 12 product codes. Dated history runs from Jan 26, 1981 to Dec 4, 2008.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

38 matching records
Device / recordCompany in FDA recordSourceSource date
ANA Fluorescent Test System and ANA Colorzyme Test System, Sub assembly catalog number SA 2013, Kit Catalog Numbers, 2000, 2002, 2003, 2004, 2005…Z-1044-2009 · DHNImmuno Concepts IncRecallApr 6, 2009FDA classification date
RELISA ENA Multiparameter Antibody Screening test, enzyme immunoassay test system, manufactured by Immuno Concepts N.A. Ltd., Sacramento, CA.Z-1045-2009 · LLLImmuno Concepts IncRecallApr 6, 2009FDA classification date
IGG ANTI-NDNA FLUORESCENT TEST SYSTEM; MODEL # 3040GK013432 · KTLImmuno Concepts, Inc.510(k)Nov 29, 2001FDA decision date
RELISA PR3-ANCA TEST SYSTEM FOR ANTIBODIES TO PROTEINASE 3, MODEL # 7096-16K013283 · MOBImmuno Concepts, Inc.510(k)Nov 14, 2001FDA decision date
RELISA MPO-ANCA TEST SYSTEM FOR ANTIBODIES TO MYELOPEROXIDASE, MODEL # 7096-15K013285 · MOBImmuno Concepts, Inc.510(k)Nov 14, 2001FDA decision date
RELISA ANA SCREENING TEST SYSTEM, MODEL 7096-11K992041 · LJMImmuno Concepts, Inc.510(k)Jul 23, 1999FDA decision date
HEP-2000 COLORZYME ANA-RO TEST SYSTEM, MODEL 4200-ROK983924 · DHNImmuno Concepts, Inc.510(k)Dec 18, 1998FDA decision date
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEMK972145 · DHNImmuno Concepts, Inc.510(k)Feb 24, 1998FDA decision date
IMMUNO CONCEPTS ANCA TEST SYSTEMK974463 · MOBImmuno Concepts, Inc.510(k)Feb 9, 1998FDA decision date
IMMUNO CONCEPTS ANCA TEST SYSTEMSK974478 · MOBImmuno Concepts, Inc.510(k)Feb 9, 1998FDA decision date
RELISA ENA SINGLE WELL SCREEN ANTIBODY TEST SYSTEMK963275 · LLLImmuno Concepts, Inc.510(k)Sep 13, 1996FDA decision date
RELSIA SCL-70 ANTIBODY TEST SYSTEMK955602 · LLLImmuno Concepts, Inc.510(k)Apr 19, 1996FDA decision date
RELSIA SS-A/RO & SS/B LA ANTIBODY TEST SYSTEMK955603 · LLLImmuno Concepts, Inc.510(k)Apr 19, 1996FDA decision date
RELISA SM/RNP ANTIBODY TEST SYSTEMK955604 · LLLImmuno Concepts, Inc.510(k)Apr 19, 1996FDA decision date
RELISA JO-1 ANTIBODY TEST SYSTEMK955605 · LLLImmuno Concepts, Inc.510(k)Apr 19, 1996FDA decision date
HEP-2000 COLORZYME ANA-RO TEST SYSTEMK950979 · DHNImmuno Concepts, Inc.510(k)Jun 1, 1995FDA decision date
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEMK944096 · DHNImmuno Concepts, Inc.510(k)Nov 21, 1994FDA decision date
RELISA ENA ANTIBODY SCREENING TEST SYSTEMK935129 · LLLImmuno Concepts, Inc.510(k)Jan 31, 1994FDA decision date
ANTI-CARDIOLIPIN ANTIBODY SCREENING TEST SYSTEMK932225 · MIDImmuno Concepts, Inc.510(k)Jul 6, 1993FDA decision date
ANTI-CARDIOLIPIN ANTIBODY TEST SYSTEMK911661 · MIDImmuno Concepts, Inc.510(k)Dec 9, 1991FDA decision date
FLUORECENT EBV-EARLY ANTIGEN IGG ANTIBODY TEST SYSK912488 · LSEImmuno Concepts, Inc.510(k)Jul 24, 1991FDA decision date
COLORZYME EBV EARLY ANTIGEN IGG ANTIBODY TEST SYSK912489 · LSEImmuno Concepts, Inc.510(k)Jul 24, 1991FDA decision date
EBNA ANTIBODY TEST SYSTEM (IMMUNOFLUORESCENT ANTI)K895708 · LLMImmuno Concepts, Inc.510(k)Dec 11, 1989FDA decision date
EBNA ANTIBODY TEST SYSTEM (IMMUNOENZYME ANTIBODY)K895707 · LLMImmuno Concepts, Inc.510(k)Dec 8, 1989FDA decision date
CMV IGM ANTIBODY TEST (INDIRECT FLUORESCENT TEST)K893465 · LKQImmuno Concepts, Inc.510(k)Jul 25, 1989FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗